For the quarter ending 2026-03-31, XBIO has $7,908,991 in assets. $958,239 in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 7,347,255 | 7,883,632 | 4,121,599 | 4,779,846 |
| Prepaid expenses and other | 247,815 | 166,294 | 946,361 | 573,854 |
| Total current assets | 7,595,070 | 8,049,926 | 5,067,960 | 5,353,700 |
| Other assets | 313,921 | 313,921 | 0 | 0 |
| Total assets | 7,908,991 | 8,363,847 | 5,067,960 | 5,353,700 |
| Accounts payable | 558,808 | 258,109 | 578,250 | 346,828 |
| Accrued expenses and other current liabilities | 399,431 | 709,916 | 533,525 | 556,602 |
| Total current liabilities | 958,239 | 968,025 | 1,111,775 | 903,430 |
| Total liabilities | 958,239 | 968,025 | 1,111,775 | 903,430 |
| Preferred stock, value | 1,454 | 1,454 | 1,804 | 1,804 |
| Common stock, 0.001 par value 10,000,000 shares authorized as of march 31, 2026 and december 31, 2025 2,293,757 shares issued as of march 31, 2026 and december 31, 2025 2,291,056 shares outstanding as of march 31, 2026 and december 31, 2025 | 2,294 | 2,294 | 1,545 | 1,545 |
| Additional paid in capital | 212,306,163 | 212,294,851 | 208,276,537 | 208,260,682 |
| Accumulated deficit | -200,331,713 | -199,875,331 | -199,296,255 | -198,786,315 |
| Accumulated other comprehensive income | 253,734 | 253,734 | 253,734 | 253,734 |
| Treasury stock | 5,281,180 | 5,281,180 | 5,281,180 | 5,281,180 |
| Total stockholders' equity | 6,950,752 | 7,395,822 | 3,956,185 | 4,450,270 |
| Total liabilities and stockholders' equity | 7,908,991 | 8,363,847 | 5,067,960 | 5,353,700 |
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO)